^
Phase 1
GlaxoSmithKline
Completed
Last update posted :
11/20/2020
Initiation :
07/02/2010
Primary completion :
02/11/2014
Completion :
12/19/2016
PRAME
|
PRAME expression
|
GSK2302025A • GSK2302032A